Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | CAMKK1 | Q8N5S9 | 1/20 | 0.30 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20090115 | 0.93 | KMT2A (0.36) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090131 | 0.90 | HPGD (0.39) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090234 | 0.89 | ALDH1A1 (0.34) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090086 | 0.88 | ALDH1A1 (0.39) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL18118576 | 0.88 | HPGD (0.38) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090127 | 0.86 | ALDH1A1 (0.41) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL14644211 | 0.86 | ALDH1A1 (0.41) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090235 | 0.86 | HPGD (0.35) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090193 | 0.86 | UTRN (0.32) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20090223 | 0.84 | HPGD (0.34) | ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.